9621 Agnes Crossing, Lake Suzanneview, New Mexico Island 84604-9295.
BioNTech, whose name we often hear with Covid-19 during the pandemic period, with the Covid-19 vaccines it produces. millions of lives saved. In fact, Uğur Şahin, the CEO
BioNTech, whose name we often hear with Covid-19 during the pandemic period, with the Covid-19 vaccines it produces. millions of lives saved. In fact, Uğur Şahin, the CEO of the company, made a statement last year with the support of the Gates Foundation. that they will start laboratory testing of tuberculosis and malaria vaccines had explained.
Today, German healthcare giant BioNTech, an artificial intelligence technology company of Tunisian origin but headquartered in the UK, announces acquisition of InstaDeep. So, for what purpose will BioNTech, a pharmaceutical company, use artificial intelligence?
Founded in 2014, InstaDeep launched last January. received an investment of $100 million and took its place among the big artificial intelligence companies. Mainly used in the fields of biology, logistics and energy producing custom artificial intelligence systems The company was seen as a company with a lot of potential. In the statement made today on InstaDeep’s official site, it was announced that the company has been purchased by BioNTech for a total amount of USD 680 million (TL 12,770,984,800).
Of the $438 million in cash and BioNTech stock, the remaining $200 million will go to InstaDeep under the agreement. will be paid based on future performance. While the deal is not fully known in detail, an official statement has been made as to why InstaDeep was purchased.
So what will a pharmaceutical company like BioNTech do if they buy InstaDeep? According to the statement, the German pharmaceutical giant is leveraging InstaDeep’s innovative technologies. will discover, test and develop new medicines with artificial intelligence. Developing drugs for specific diseases is a very long and challenging process and all possible alternatives must be tried and tested one by one. As a result, drug testing phases take months, sometimes even years. Here’s BioNTech using InstaDeep’s artificial intelligence. aims to shorten the testing process and accelerate the discovery of new drugs.
While BioNTech has announced that it will use artificial intelligence and machine learning in the drug development and testing phase, it has announced when this new technology will be used. But it seems very fast even our medicines will start producing artificial intelligence.
Source: Web Tekno
Alice Smith is a seasoned journalist and writer for Div Bracket. She has a keen sense of what’s important and is always on top of the latest trends. Alice provides in-depth coverage of the most talked-about news stories, delivering insightful and thought-provoking articles that keep her readers informed and engaged.
